Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
Steven Borson(UPMC Hillman Cancer Center), Dan P. Zandberg(University of Pittsburgh Medical Center), Barton F. Branstetter(University of Pittsburgh Medical Center), Heath D. Skinner(University of Pittsburgh), David A. Clump(West Virginia University), Moon J. Fenton(University of Tennessee Health Science Center), Mark Kubik(UPMC Hillman Cancer Center), Umamaheswar Duvvuri(City University of New York), Shaum Sridharan(University of Pittsburgh), James Ohr(University of Pittsburgh), Simion I. Chiosea(University of Pittsburgh), Marci L. Nilsen(University of Pittsburgh), Marion A. Hughes(University of Pittsburgh Medical Center), Robert L. Ferris(University of Pittsburgh), Seungwon Kim(UPMC Hillman Cancer Center), Jonas T. Johnson(University of Pittsburgh), Yongli Shuai(UPMC Hillman Cancer Center), Katie Traylor(University of Pittsburgh Medical Center)
Cited by 13
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632